🔗 Visit the ClinicalTrials.gov page for NCT01357486
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Sorafenib in advanced hepatocellular carcinoma. | N Engl J Med | 2008 | 54.30 |
| 2 | Design and endpoints of clinical trials in hepatocellular carcinoma. | J Natl Cancer Inst | 2008 | 11.27 |
| 3 | An assessment of statin safety by hepatologists. | Am J Cardiol | 2006 | 1.78 |
| 4 | Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial. | Br J Cancer | 2001 | 1.47 |
| 5 | Pravastatin reduces lung metastasis of rat hepatocellular carcinoma via a coordinated decrease of MMP expression and activity. | J Hepatol | 2006 | 0.94 |
| 6 | Treatment of HCC with pravastatin, octreotide, or gemcitabine--a critical evaluation. | Hepatogastroenterology | 2004 | 0.86 |
| 7 | Hepatocellular carcinoma: Will novel targeted drugs really impact the next future? | World J Gastroenterol | 2016 | 0.76 |